Why 23andMe Is Betting Big On An Open Science Model
On this episode oof Iconoclast, 23andMe CEO and Founder Anne Wojcicki sits down with Forbes to discuss 23andMe’s transformation from a public direct-to-consumer genetic testing company into a nonprofit research institute focused on preventative health. Wojcicki also discusses her personal family history with healthcare advocacy, the lessons she learned from navigating a complex public market corporate restructuring, and the company's citizen-powered open science platform.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.